Resultados de búsqueda - Jonas Mandel

  • Mostrando 1 - 6 Resultados de 6
Limitar resultados
  1. 1
    No evidence of neurocognitive adverse events associated with alirocumab treatment in 3340 patients from 14 randomized Phase 2 and 3 controlled trials: a meta-analysis of individual patient data

    No evidence of neurocognitive adverse events associated with alirocumab treatment in 3340 patients from 14 randomized Phase 2 and 3 controlled trials: a meta-analysis of individual... por Philip D. Harvey, Marwan N. Sabbagh, John Harrison, Henry N. Ginsberg, M. John Chapman, Garen Manvelian, Angèle Moryusef, Jonas Mandel, Michel Farnier

    Publicado 2017
    Enlace del recurso Enlace del recurso
    Revisão
    Agregar a favoritos
    Guardado en:
  2. 2
    Efficacy and safety of lipid lowering by alirocumab in chronic kidney disease

    Efficacy and safety of lipid lowering by alirocumab in chronic kidney disease por Peter P. Tóth, Jamie P. Dwyer, Christopher P. Cannon, Helen M. Colhoun, Daniel J. Rader, Ashish Upadhyay, Michael J. Louie, Andrew Koren, Alexia Letierce, Jonas Mandel, Maciej Banach

    Publicado 2018
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  3. 3
    Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies

    Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies por Kausik K. Ray, Stefano Del Prato, Dirk Müller‐Wieland, Bertrand Cariou, Helen M. Colhoun, Francisco J. Tinahones, Catherine Domenger, Alexia Letierce, Jonas Mandel, Rita Samuel, Maja Bujas‐Bobanovic, Lawrence A. Leiter

    Publicado 2019
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  4. 4
    Efficacy and safety of alirocumab in insulin‐treated individuals with type 1 or type 2 diabetes and high cardiovascular risk: The <scp>ODYSSEY DM‐INSULIN</scp> randomized trial

    Efficacy and safety of alirocumab in insulin‐treated individuals with type 1 or type 2 diabetes and high cardiovascular risk: The <scp>ODYSSEY DM‐INSULIN</scp> randomized trial por Lawrence A. Leiter, Bertrand Cariou, Dirk Müller‐Wieland, Helen M. Colhoun, Stefano Del Prato, Francisco J. Tinahones, Kausik K. Ray, Maja Bujas‐Bobanovic, Catherine Domenger, Jonas Mandel, Rita Samuel, Robert R. Henry

    Publicado 2017
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  5. 5
    Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy

    Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1... por Ilya Chumakov, Aude Milet, Nathalie Cholet, Gwenaël Primas, Aurélie Boucard, Yannick Pereira, Esther Graudens, Jonas Mandel, Julien Laffaire, Julie Foucquier, Fabrice Glibert, Viviane Bertrand, Klaus‐Armin Nave, Michael W. Sereda, Emmanuel Vial, Mickaël Guedj, Rodolphe Hajj, Serguei Nabirotchkin, Daniel Cohen

    Publicado 2014
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:
  6. 6
    An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A

    An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth dis... por Shahram Attarian, Jean‐Michel Vallat, Laurent Magy, Benoît Funalot, Pierre‐Marie Gonnaud, Arnaud Lacour, Yann Péréon, O. Dubourg, Jean Pouget, Joëlle Micallef, J. Franques, Marie‐Noëlle Lefebvre, Karima Ghorab, Mahmoud Al-Moussawi, V. Tiffreau, Marguerite Preudhomme, Armelle Magot, Laurène Leclair‐Visonneau, Tanya Stojkovic, Laura Bossi, Philippe Lehert, Walter Gilbert, Viviane Bertrand, Jonas Mandel, Aude Milet, Rodolphe Hajj, Lamia Boudiaf, Catherine Scart‐Grès, Serguei Nabirotchkin, Mickaël Guedj, Ilya Chumakov, Daniel Cohen

    Publicado 2014
    Enlace del recurso Enlace del recurso
    Artigo
    Agregar a favoritos
    Guardado en:

Herramientas de búsqueda: